If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...

Professor Joanna Moncrieff’s new book Chemically Unbalanced further calls for greater patient consent provisions to inform ...

If you’ve been diagnosed with major depressive disorder or a form of anxiety, your mental health provider may prescribe the ...

The selective serotonin reuptake inhibitor sertraline is often among the preferred antidepressants to take when breastfeeding ...

The NHS specifically warns patients taking selective serotonin reuptake inhibitors (SSRIs) and serotonin-noradrenaline ...

The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...

Government plans to create ‘neighbourhood health centres’ as Dr Simon Opher proposes drafting psychologists into practices ...

The U.S. Food and Drug Administration has approved a nasal spray that is known to help treat depression.

Despite being a first-line treatment for adolescent depression and anxiety, antidepressant drugs appear to have questionable efficacy and carry an increased risk of adverse effects in this population.

In the logistic regression model of the top 20 factors, significant associations for semaglutide initiation included being female (adjusted odds ratio, 2.30), using certain medication classes ...

While antipsychotics can be effective for some patients, they come with well-known side effects, including an increased risk ...

The FDA approved Spravato for those battling depression and has seen little to no improvement from two types of ...